ENTITY
GenSci144
GenSci144
PulseAugur coverage of GenSci144 — every cluster mentioning GenSci144 across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
Shenyang Blower Works Group IPO approved; Moonshot AI raises $3.5B
Shenyang Blower Works Group has received approval from the China Securities Regulatory Commission to list on the Shanghai Stock Exchange's main board. In other news, a subsidiary of Changchun High-Tech, Jinsai Pharma, h…
-
GenSci144 drug for chronic kidney disease gains Chinese clinical trial approval
GenSci144, an oral small molecule inhibitor developed by Jinsai Pharmaceutical, has received approval for its clinical trial application in China. This drug targets the neutral amino acid transporter SLC6A19 and is inte…